Left ventricular hypertrophy and preclinical impaired glucose tolerance and diabetes mellitus contribute to abnormal left ventricular diastolic function in hypertensive patients

被引:6
作者
Salmasi, AM
Rawlins, S
Dancy, M
机构
[1] Cent Middlesex Hosp, Dept Cardiac, Cardiac Res Unit, London NW10 7NS, England
[2] Cent Middlesex Hosp, Hypertens Clin, Dept Cardiol, London NW10 7NS, England
关键词
glucose intolerance; hypertension; left ventricular hypertrophy; left ventricular filling; diastolic left ventricular function; diabetes;
D O I
10.1097/01.mbp.0000172710.82287.36
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background Impaired left ventricular diastolic function is not uncommon in patients with either diabetes mellitus or hypertension. This study was carried out to assess the contribution of left ventricular hypertrophy, high blood pressure, preclinical impaired glucose tolerance and diabetes mellitus to left ventricular diastolic function in patients attending a hypertension clinic. Methods Echocardiography, 24-h ambulatory blood pressure monitoring and oral glucose tolerance tests were carried out in 152 consecutive hypertensive patients who had no evidence of ischaemic heart disease and were not known to be diabetic. From echocardiography, E/A (peak velocity of early/atrial filling waves of the transmitral flow) at rest and at peak standardized isometric exercise using handgrip, left ventricular mass index and deceleration time of the E wave were derived. Results Patients with impaired glucose tolerance and diabetes mellitus had lower E/A than the euglycaemic subjects both at rest (P=0.0073) and during isometric exercise (P < 0.0001). E/A significantly reduced during isometric exercise in patients with impaired glucose tolerance and diabetes but not in euglycaemic patients. Deceleration time was shortened with a worsening degree of glucose intolerance in all the patients (P=0.0005), in those with left ventricular hypertrophy (P=0.0006) and in those without left ventricular hypertrophy (P=0.033). When adjusted for age, gender, race, body mass index, smoking history, ambulatory blood pressure findings, cholesterol and triglyceride levels and anti hypertensive medications taken, E/A at isometric exercise was related to results of glucose tolerance tests and was inversely proportional to left ventricular mass index (P < 0.0001). No significant differences were found whether patients were taking anti hypertensive medications or not. Conclusion In hypertensive patients, left ventricular diastolic function is determined by left ventricular mass index and the status of preclinical glucose intolerance, independent of age, gender, race, body mass index, blood pressure level, nocturnal drop in blood pressure or lipid level. These findings were not prejudiced by anti hypertensive medications.
引用
收藏
页码:231 / 238
页数:8
相关论文
共 42 条
[1]   Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension [J].
Aeschbacher, BC ;
Hutter, D ;
Fuhrer, J ;
Weidmann, P ;
Delacrétaz, E ;
Allemann, Y .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (02) :106-113
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   Determinants of left ventricular mass in untreated mildly hypertensive subjects -: Hospitalet study in mild hypertension [J].
Armario, P ;
del Rey, RH ;
Sánchez, P ;
Martín-Baranera, M ;
Torres, G ;
Juliá, J ;
Pardell, H .
AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (11) :1084-1090
[5]   ACCURACY AND REPRODUCIBILITY OF CLINICALLY ACQUIRED TWO-DIMENSIONAL ECHOCARDIOGRAPHIC MASS MEASUREMENTS [J].
BYRD, BF ;
FINKBEINER, W ;
BOUCHARD, A ;
SILVERMAN, NH ;
SCHILLER, NB .
AMERICAN HEART JOURNAL, 1989, 118 (01) :133-137
[6]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[7]   Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study [J].
de Simone, G ;
Palmieri, V ;
Bella, JN ;
Celentano, A ;
Hong, YL ;
Oberman, A ;
Kitzman, DW ;
Hopkins, PN ;
Arnett, DK ;
Devereux, RB .
JOURNAL OF HYPERTENSION, 2002, 20 (02) :323-331
[8]   ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR HYPERTROPHY - COMPARISON TO NECROPSY FINDINGS [J].
DEVEREUX, RB ;
ALONSO, DR ;
LUTAS, EM ;
GOTTLIEB, GJ ;
CAMPO, E ;
SACHS, I ;
REICHEK, N .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (06) :450-458
[9]   Impact of diabetes on cardiac structure and function - The strong heart study [J].
Devereux, RB ;
Roman, MJ ;
Paranicas, M ;
O'Grady, MJ ;
Lee, ET ;
Welty, TK ;
Fabsitz, RR ;
Robbins, D ;
Rhoades, ER ;
Howard, BV .
CIRCULATION, 2000, 101 (19) :2271-2276
[10]   Effect of blood glucose on left ventricular mass in patients with hypertension and type 2 diabetes mellitus [J].
Felicio, JS ;
Ferreira, SRG ;
Plavnik, FL ;
Moisés, V ;
Kohlmann, O ;
Ribeiro, AB ;
Zannella, MT .
AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (11) :1149-1154